Petty Margaret A, Lo Eng H
CNS Pharmacology, Aventis Pharmaceuticals Inc., Route 202-206, P.O. Box 6800, Bridgewater, NJ 08807, USA.
Prog Neurobiol. 2002 Dec;68(5):311-23. doi: 10.1016/s0301-0082(02)00128-4.
A wide range of central nervous system (CNS) disorders include neuroinflammatory events that perturb blood-brain barrier (BBB) integrity. Mechanisms by which the BBB responds to physiological and pathological stimuli involve signaling systems in the tight and adherens junctions of the cerebral endothelium. In this review, we examine the molecular composition and regulatory mediators that control BBB permeability and assess how these mediators may be dysregulated in stroke, multiple sclerosis, brain tumors, and meningioencephalitis. An understanding of these molecular substrates in BBB regulation may lead to new approaches for enhancing CNS drug delivery and ameliorating brain edema after injury and inflammation.
多种中枢神经系统(CNS)疾病都包括扰乱血脑屏障(BBB)完整性的神经炎症事件。血脑屏障对生理和病理刺激作出反应的机制涉及脑内皮紧密连接和黏附连接中的信号系统。在本综述中,我们研究了控制血脑屏障通透性的分子组成和调节介质,并评估了这些介质在中风、多发性硬化症、脑肿瘤和脑膜脑炎中可能如何失调。了解血脑屏障调节中的这些分子底物可能会带来增强中枢神经系统药物递送以及减轻损伤和炎症后脑水肿的新方法。